Ibudilast

This classification denotes a vasodilating agent and antiplatelet agent with the molecular formula C14H18N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M0TTH61XC5, chemically known as 3-isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine but generally known as ibudilast, which bears US NIH Compound Identifier 3671. European Medicines Agency schedules Ibudilast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08096MIG. The term IBUDILAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, No. 3, 1988, List 28). World Health Organization schedules ibudilast in its Anatomical Therapeutic Chemical (ATC) Classification. IBUDILAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibudilast under HS 29339990 and SITC 51577. As of Q4 2014, IBUDILAST remains the US FDA Preferred Term for this commodity. Ibudilast bears US NLM identifiers UMLS ID C0123047 and NCI Concept Code C65876. SMILES: O=C(c1c(nn2c1cccc2)C(C)C)C(C)C.